We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Blood Test Detects Brain Damage Years before Symptoms

By LabMedica International staff writers
Posted on 07 Feb 2019
Alzheimer's disease is a major cause of dementia that destroys brain cells and tissue. More...
As the brain damage spreads, it leads to symptoms such as confusion, memory loss, and diminishing capacity to function. Eventually, the person can no longer lead an independent life.

Postmortem exams of the brains of people with Alzheimer's disease reveal three typical hallmarks: plaques of beta-amyloid protein, tangles of tau protein, and loss of connections between brain cells. Alzheimer's disease mostly strikes people aged 65 years and older, but there are rarer forms that can strike earlier.

A team including scientists from the Washington University School of Medicine in St. Louis, (MO, USA) and the German Center for Neurodegenerative Diseases (Tübingen, Germany) studied a rare form that has the name dominantly inherited Alzheimer's disease (DIAD), or autosomal dominant Alzheimer's disease. The data for the study came from the Dominantly Inherited Alzheimer's Network (DIAN), which is an international consortium. The analysis took in data on more than 400 people in the DIAN network. This number included 247 who were carriers of a genetic mutation and 162 of their blood relatives who were not carriers. All the individuals had attended a DIAN clinic and given a blood sample, completed cognition tests of memory and thinking skills, and undergone brain scans. In addition, around half had made repeat clinic visits, with up to three years between each.

Neurofilament light chain (NfL) is a promising fluid biomarker of disease progression for various cerebral proteopathies. Examination of the blood samples from the first visit revealed higher levels of NfL in those people who carried a gene mutation. In these individuals, repeated visits showed NfL levels rising over time. The individuals who did not carry a gene mutation, however, did not show this pattern. Their NfL levels were lower and remained fairly steady over time. The team detected the rise in NfL levels some 16 years before the anticipated onset of symptoms. The team used ultrasensitive immunoassay technology to demonstrate that NfL levels in the cerebrospinal fluid and serum are correlated with one another and are elevated at the presymptomatic stages of familial Alzheimer’s disease.

Further analysis revealed that NfL levels were also predictive for the decline in memory and thinking skills in the cognition tests. Other conditions that damage the brain can also cause neurons to leak NfL. People with Huntington's disease and Lewy body dementia, for example, have higher blood levels of the protein. Blood NfL levels also rise in football players immediately after a blow to the head and in people with multiple sclerosis during flare-ups.

The authors concluded that NfL dynamics in serum predict disease progression and brain neurodegeneration at the early presymptomatic stages of familial Alzheimer’s disease, which supports its potential utility as a clinically useful biomarker. Brian Gordon, PhD, who is an assistant professor of radiology and co-author of the study, said, “This is something that would be easy to incorporate into a screening test in a neurology clinic.” The study was published on January 21, 2019, in the journal Nature Medicine.

Related Links:
Washington University School of Medicine
German Center for Neurodegenerative Diseases


Gold Member
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Serological Pipet Controller
PIPETBOY GENIUS
New
PlGF Test
Quidel Triage PlGF Test
New
Hand-Held Immunofluorescence Analyzer
WS-Si1500
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: A simple blood test could replace surgical biopsies for early detecion of heart transplant rejection (Photo courtesy of Shutterstock)

Blood Test Detects Organ Rejection in Heart Transplant Patients

Following a heart transplant, patients are required to undergo surgical biopsies so that physicians can assess the possibility of organ rejection. Rejection happens when the recipient’s immune system identifies... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.